In a very short time, says Unilife CEO Alan Shortall, the company has grown and rapidly expanded. Following a move from Australia to the United States, Unilife with Alan Shortall at the helm has seen the power of hiring great people. In fact Unilife, Alan Shortall says, has “over the last 8.5 years gone from employing three people to where we now employ over 150 people.”
For Unilife’s Alan Shortall a portion of the success of a company has to be about the people in which they are hiring. “For centuries people have rallied around causes,” says Unilife CEO Alan Shortall. He points out that what is being performed by Unilife is clearly a cause. “What we are doing is going to save a lot of lives,” Unilife’s Alan Shortall notes.
And the cause of Unilife, Alan Shortall believes, is one of the reasons why the company is “attracting high quality people.” The excitement of “doing something worthwhile [and] the idea of being able to actually leave a worthwhile legacy behind” has attracted a number of high caliber people to Unilife, Alan Shortall maintains. People want to work for and with Unilife, Alan Shortall says, because the company culture is “innovative and creative” while making a difference.
These high caliber people are landing in many different positions with Unilife, including product development. “We have a team of people that are actually developing products for us,” says Unilife’s CEO Alan Shortall. Further explaining what is taking place in product development at Unilife, Shortall adds, “We’ve already demonstrated our ability to be creative and innovative by doing the impossible with the Unifill. That same expertise is now developing a team of new products that are coming through the pipeline.”
Unilife Corporation is a U.S. based developer and manufacturer of a diversified portfolio of advanced drug delivery systems. Since CEO and Executive Director Alan Shortall founded Unilife in 2002, he has been a principal driving force behind the company’s rapid global expansion. At Unilife, Alan Shortall has led the Company in the development, patent-protection and diversification of its broad device portfolio, which includes a best-in-class technology platform of safety syringes. As the leader of Unilife, Alan Shortall has also attracted world-class experts from the pharmaceutical and medical device industries to the Board and executive management team.
Between 2008 and 2010, Alan Shortall spearheaded Unilife’s transition from Australia to a fully based and registered U.S. business. This included the redomiciliation of Unilife by Alan Shortall and associates into a Delaware registered Company, and its listing on the NASDAQ stock exchange (NASDAQ:UNIS) in February 2010. Unilife also continues to trade on the Australian Stock Exchange (UNS:ASX).